Proteome Sciences PLC Holding(s) in Company (7701D)
April 28 2017 - 10:54AM
UK Regulatory
TIDMPRM
RNS Number : 7701D
Proteome Sciences PLC
28 April 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------------------------------------------------
1. Identity of the issuer or PROTEOME SCIENCES PLC
the underlying issuer
of existing shares to which
voting rights are
attached: (ii)
------------------------------------------------------------- -----------------------------
2 Reason for the notification (please tick the appropriate
box or boxes):
--------------------------------------------------------------------------------------------
An acquisition or disposal of voting rights YES
---------------------------------------------------------------- --------------------------
An acquisition or disposal of qualifying financial
instruments which may result in the acquisition
of shares already issued to which voting rights
are attached
---------------------------------------------------------------- --------------------------
An acquisition or disposal of instruments with
similar economic effect to qualifying financial
instruments
---------------------------------------------------------------- --------------------------
An event changing the breakdown of voting rights
---------------------------------------------------------------- --------------------------
Other (please
specify):
------------------------------------------------------- ------- --------------------------
3. Full name of person(s) VULPES LIFE SCIENCES FUND
subject to the VULPES TESTUDO FUND
notification obligation:
(iii)
--------------------------------------------------------- ---------------------------------
4. Full name of shareholder(s)
(if different from 3.):(iv)
--------------------------------------------------------- ---------------------------------
5. Date of the transaction 27 APRIL 2017
and date on
which the threshold is
crossed or
reached: (v)
--------------------------------------------------------- ---------------------------------
6. Date on which issuer 28 APRIL 2017
notified:
--------------------------------------------------------- ---------------------------------
7. Threshold(s) that is/are >18%
crossed or
reached: (vi, vii)
--------------------------------------------------------- ---------------------------------
8. Notified details:
----------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
----------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the
of to the triggering triggering transaction
shares transaction
if possible
using
the ISIN
CODE
------------- -------------------------------- ---------------------------------------------------------------------
Number Number Number Number of voting % of voting
of of of shares rights rights (x)
Shares Voting
Rights
------------- --------------- --------------- ------------- --------------------------- -------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
------------- ----------- ----------- ------------- ------------- ------------ ------------ -----------
GB0003104196 53,943,715 53,943,715 54,043,715 54,043,715 18.34%
--------------- --------------- ------------- ------------- ------------ ------------ -----------
B: Qualifying Financial Instruments
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Expiration Exercise/ Number of voting % of voting
financial date Conversion rights that rights
instrument (xiii) Period (xiv) may be
acquired if
the
instrument is
exercised/ converted.
----------------- ------------- ------------------------------ ----------------------------- ---------------------
C: Financial Instruments with similar economic effect
to Qualifying Financial Instruments (xv, xvi)
----------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
----------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date Conversion rights instrument rights
instrument (xvii) period refers to (xix, xx)
(xviii)
--------------- ------------- ------------- --------------- ----------------------------- -----------------------
Nominal Delta
--------------- ------------- ------------- --------------- ----------------------------- ------------ ---------
Total (A+B+C)
----------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
------------------------------------------------- -------------------------------------------------------------------
54,043,715 18.34%
------------------------------------------------- -------------------------------------------------------------------
9. Chain of controlled undertakings through which the
voting rights and/or the
financial instruments are effectively held, if applicable:
(xxi)
---------------------------------------------------------------------------------------------
Proxy Voting:
---------------------------------------------------------------------------------------------
10. Name of the proxy holder:
-------------------------------------------------------------- -----------------------------
11. Number of voting rights proxy
holder will cease
to hold:
-------------------------------------------------------------- -----------------------------
12. Date on which proxy holder will
cease to hold
voting rights:
-------------------------------------------------------------- -----------------------------
executive.pa@proteomics.com
13. Additional information:
------------------------------------------------------------ -------------------------------
14. Contact name: Victoria Birse
------------------------------------------------------------ -------------------------------
15. Contact telephone number:
------------------------------------------------------------ -------------------------------
Note: Annex should only be submitted to the FCA not
the issuer
Annex: Notification of major interests in share
A: Identity of the persons or legal entity subject to
the notification obligation
-----------------------------------------------------------------------
Full name VULPES LIFE SCIENCES FUND
(including legal form of
legal entities)
------------------------------------ ---------------------------------
Contact address c/o Maples Corporate Services
(registered office for legal Limited, PO
entities) Box 309, Ugland House, Grand
Cayman, KY1-1104, Cayman
Islands
------------------------------------ ---------------------------------
Phone number & email
------------------------------------ ---------------------------------
Other useful information
(at least legal representative
for legal persons)
------------------------------------ ---------------------------------
B: Identity of the notifier, if applicable
-----------------------------------------------------------------------
Full name Stephen Diggle
------------------------------------ ---------------------------------
Contact address One George Street #07-03
Singapore 049145
------------------------------------ ---------------------------------
Phone number & email Tel: (65) 6538 1998 (Main)
Email: sdiggle@vulpesinvest.com
------------------------------------ ---------------------------------
Other useful information Director
(e.g. functional relationship
with the person or legal
entity subject to the notification
obligation)
------------------------------------ ---------------------------------
C: Additional information
-----------------------------------------------------------------------
Email address: Complete the required TR-1 form and email
it to: Major shareholdings majorshareholdings@fca.gov.uk
Fax number: You can print the TR-1 form, complete it
and fax it to: 020 7066 0050
-----------------------------------------------------------------------
For notes on how to complete form TR-1 please see the
FCA website.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLPGUBCCUPMGAR
(END) Dow Jones Newswires
April 28, 2017 11:54 ET (15:54 GMT)
Proteome Sciences (LSE:PRM)
Historical Stock Chart
From Apr 2024 to May 2024
Proteome Sciences (LSE:PRM)
Historical Stock Chart
From May 2023 to May 2024
